» Articles » PMID: 1357954

Regression of Left Ventricular Hypertrophy in Systemic Hypertension with Beta Blockers (propranolol, Atenolol, Metoprolol, Pindolol and Celiprolol)

Overview
Journal Am J Cardiol
Date 1992 Nov 1
PMID 1357954
Citations 5
Authors
Affiliations
Soon will be listed here.
Citing Articles

Echocardiographic Assessment in Patients with Vascular Ehlers-Danlos Syndrome: Insights from an Unexplored Field.

Buso G, Paini A, Agabiti-Rosei C, Bertacchini F, Stassaldi D, Capellini S High Blood Press Cardiovasc Prev. 2024; 32(1):79-86.

PMID: 39488620 DOI: 10.1007/s40292-024-00692-8.


Celiprolol: A Unique Selective Adrenoceptor Modulator.

Nawarskas J, Cheng-Lai A, Frishman W Cardiol Rev. 2017; 25(5):247-253.

PMID: 28742547 PMC: 5549637. DOI: 10.1097/CRD.0000000000000159.


Reduction by oral propranolol treatment of left ventricular hypertrophy secondary to pressure-overload in the rat.

Ostman-Smith I Br J Pharmacol. 1995; 116(6):2703-9.

PMID: 8590993 PMC: 1909123. DOI: 10.1111/j.1476-5381.1995.tb17230.x.


Celiprolol. An evaluation of its pharmacological properties and clinical efficacy in the management of hypertension and angina pectoris.

Dunn C, Spencer C Drugs Aging. 1995; 7(5):394-411.

PMID: 8573993 DOI: 10.2165/00002512-199507050-00006.


Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality.

Kaplinsky E Cardiovasc Drugs Ther. 1994; 8 Suppl 3:549-56.

PMID: 7841088 DOI: 10.1007/BF00877223.